Want to join the conversation?
Investment manager $TROW reported a lower quarterly profit, hurt by charge. The company reported 2Q16 earnings of $195.3MM, or $.76 per share, compared to earnings of $333.2MM, or $1.24 per share a year ago. 2Q16 results included an operating charge of $166.2MM, the company said. Assets under management increased to $776.6Bil at June 30, 2016.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.